Chronic activation of AMP-activated kinase as a strategy for slowing aging - PubMed (original) (raw)
Chronic activation of AMP-activated kinase as a strategy for slowing aging
Mark F McCarty. Med Hypotheses. 2004.
Abstract
Caloric restriction down-regulates insulin secretion and systemic IGF-I activity, and there is reason to suspect that these effects are key mediators of caloric restriction's favorable impact on longevity. Alternative strategies for down-regulating these hormones are thus of great interest; chronic activation of AMP-activated kinase (AMPK)--clinically achievable with the drug metformin--may have utility in this regard. In the liver, AMPK slows hepatic glucose output by down-regulating expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase; in skeletal muscle, it boosts the efficiency of insulin-stimulated glucose uptake by increasing expression of GLUT-4. These effects evidently mandate a down-regulation of insulin secretion. The resulting reduction of hepatic insulin activity can be expected to suppress hepatic production of IGF-I while boosting that of IGFBP-1, thereby decreasing plasma free IGF-I. AMPK can also directly stimulate IGFBP-1 synthesis in hepatocytes, and interfere with the ras/raf/erk pathway of IGF-I signaling. In non-diabetics, metformin therapy is indeed reported to reduce plasma levels of insulin and of free IGF-I; indeed, this is thought to be the mechanism whereby metformin suppresses excess androgen production in PCOS. A pro-longevity effect of the related biguanide phenformin has already been reported in tumor-prone mice, and mouse longevity studies with metformin are currently in progress. The development of AMPK activators which do not share metformin's modest risk of inducing lactic acidosis--apparently reflecting an inhibition of mitochondrial complex 1 that is not intrinsic to AMPK activity--might aid the practical applicability of this pro-longevity strategy.
Similar articles
- AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase.
McCarty MF. McCarty MF. Med Hypotheses. 2004;63(2):328-33. doi: 10.1016/j.mehy.2004.01.044. Med Hypotheses. 2004. PMID: 15236798 - Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P, Quartier E, Pipeleers D, Van de Casteele M. Huypens P, et al. Eur J Pharmacol. 2005 Aug 22;518(2-3):90-5. doi: 10.1016/j.ejphar.2005.06.016. Eur J Pharmacol. 2005. PMID: 16039647 - AMP-activated protein kinase and the metabolic syndrome.
Fryer LG, Carling D. Fryer LG, et al. Biochem Soc Trans. 2005 Apr;33(Pt 2):362-6. doi: 10.1042/BST0330362. Biochem Soc Trans. 2005. PMID: 15787607 Review. - AMP-activated protein kinase and the regulation of glucose transport.
Fujii N, Jessen N, Goodyear LJ. Fujii N, et al. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E867-77. doi: 10.1152/ajpendo.00207.2006. Epub 2006 Jul 5. Am J Physiol Endocrinol Metab. 2006. PMID: 16822958 Review.
Cited by
- Treadmill training increases SIRT-1 and PGC-1 α protein levels and AMPK phosphorylation in quadriceps of middle-aged rats in an intensity-dependent manner.
Oliveira NR, Marques SO, Luciano TF, Pauli JR, Moura LP, Caperuto E, Pieri BL, Engelmann J, Scaini G, Streck EL, Lira FS, Pinho RA, Ropelle ER, Silva AS, De Souza CT. Oliveira NR, et al. Mediators Inflamm. 2014;2014:987017. doi: 10.1155/2014/987017. Epub 2014 Jun 9. Mediators Inflamm. 2014. PMID: 25002755 Free PMC article. Retracted. - AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity.
Greer EL, Banko MR, Brunet A. Greer EL, et al. Ann N Y Acad Sci. 2009 Jul;1170:688-92. doi: 10.1111/j.1749-6632.2009.04019.x. Ann N Y Acad Sci. 2009. PMID: 19686213 Free PMC article. - Pleiotropic effects of acarbose on atherosclerosis development in rabbits are mediated via upregulating AMPK signals.
Chan KC, Yu MH, Lin MC, Huang CN, Chung DJ, Lee YJ, Wu CH, Wang CJ. Chan KC, et al. Sci Rep. 2016 Dec 7;6:38642. doi: 10.1038/srep38642. Sci Rep. 2016. PMID: 27924924 Free PMC article. - Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.
Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. Fulco M, et al. Dev Cell. 2008 May;14(5):661-73. doi: 10.1016/j.devcel.2008.02.004. Dev Cell. 2008. PMID: 18477450 Free PMC article. - (Healthy) ageing: focus on iodothyronines.
de Lange P, Cioffi F, Silvestri E, Moreno M, Goglia F, Lanni A. de Lange P, et al. Int J Mol Sci. 2013 Jul 4;14(7):13873-92. doi: 10.3390/ijms140713873. Int J Mol Sci. 2013. PMID: 23880847 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous